HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A N Murashev Selected Research

L-6-bromohypaporphine

4/2022Synthetic Analogs of 6-Bromohypaphorine, a Natural Agonist of Nicotinic Acetylcholine Receptors, Reduce Cardiac Reperfusion Injury in a Rat Model of Myocardial Ischemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A N Murashev Research Topics

Disease

5Bradycardia
11/2001 - 08/2000
3Sepsis (Septicemia)
05/2011 - 11/2006
3Shock
05/2010 - 11/2006
3Hypotension (Low Blood Pressure)
11/2001 - 09/2000
3Stroke (Strokes)
11/2001 - 09/2000
2Ischemia
04/2022 - 03/2004
2Myocardial Ischemia (Ischemic Heart Diseases)
04/2022 - 03/2004
2Hypertension (High Blood Pressure)
09/2016 - 06/2000
2Septic Shock (Toxic Shock Syndrome)
09/2014 - 11/2009
2Cicatrix (Scar)
08/2012 - 10/2009
2Infarction (Infarctions)
08/2012 - 03/2004
2Substance-Related Disorders (Drug Abuse)
04/2005 - 09/2000
1Reperfusion Injury
04/2022
1Myocardial Infarction
04/2022
1Body Weight (Weight, Body)
07/2018
1Body Temperature Changes
11/2015
1Poisoning
10/2015
1Autoimmune Diseases (Autoimmune Disease)
09/2014
1Type 2 Diabetes Mellitus (MODY)
01/2014
1Hyperphagia (Overeating)
01/2014
1Obesity
01/2014
1Alkalosis
10/2011
1Acute Pain
11/2009
1Sarcoma (Soft Tissue Sarcoma)
07/2009
1Neoplasms (Cancer)
07/2009
1Leukemia
04/2005
1Pain (Aches)
04/2005
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
03/2004
1Hypertrophy
01/2003
1Tachycardia (Tachyarrhythmias)
09/2000

Drug/Important Bio-Agent (IBA)

4Heat-Shock Proteins (Heat-Shock Protein)IBA
03/2011 - 11/2006
4moxonidine (Moxon)IBA
11/2001 - 09/2000
3HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
05/2011 - 11/2009
2Analgesics (Analgesic Drugs)IBA
11/2015 - 11/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2004 - 01/2003
1SodiumIBA
04/2022
1L-6-bromohypaporphineIBA
04/2022
1IonsIBA
04/2022
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
04/2022
1PotassiumIBA
04/2022
1lenticinIBA
04/2022
1Interleukin-6 (Interleukin 6)IBA
07/2018
1taxifolinIBA
09/2016
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
09/2016
1FlavonoidsIBA
09/2016
1Nerve AgentsIBA
10/2015
1AcidsIBA
10/2015
1Proteins (Proteins, Gene)FDA Link
09/2014
1Hypoglycemic Agents (Hypoglycemics)IBA
01/2014
1AntioxidantsIBA
01/2014
1LeptinIBA
01/2014
1insulin receptor-related receptor (IRR)IBA
10/2011
1Bicarbonates (Hydrogen Carbonate)IBA
10/2011
1Peptides (Polypeptides)IBA
11/2009
1CollagenIBA
10/2009
1SuspensionsIBA
07/2009
1threonyl- glycyl- glutamyl- asparaginyl- histidylarginineIBA
04/2005
1hydroxide ionIBA
03/2004
1Hydroxyl RadicalIBA
03/2004
1Dialysis SolutionsIBA
03/2004
1efaroxanIBA
11/2001
1Yohimbine (Yocon)IBA
04/2001
1Antidepressive Agents (Antidepressants)IBA
09/2000
1tetrindoleIBA
09/2000
1CatecholaminesIBA
09/2000
1Desipramine (Pertofrane)FDA LinkGeneric
09/2000
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
09/2000
1Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
09/2000
1Nitric Oxide Synthase (NO Synthase)IBA
08/2000
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
08/2000
1Mitochondrial DNA (mtDNA)IBA
06/2000

Therapy/Procedure

2Therapeutics
10/2015 - 05/2011
1Transplantation
08/2012
1Intravenous Administration
05/2010
1Autologous Transplantation
07/2009
1Subcutaneous Injections
07/2009
1Ligation
03/2004
1Injections
11/2001
1Intravenous Injections
11/2001
1Oral Administration
09/2000